TimesSquare Capital Management
TECH icon

TimesSquare Capital Management’s Bio-Techne TECH Stock Holding History

TimesSquare Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,100,000
Closed -$40.7M – 254
2018
Q2 		$40.7M Sell
1,100,000
-951,460
-46% -$36.3M 0.27% 142
2018
Q1 		$77.5M Buy
2,051,460
+659,460
+47% +$23.3M 0.53% 69
2017
Q4 		$45.1M Buy
+1,392,000
New +$44.2M 0.3% 125

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mairs & Power Inc
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TimesSquare Capital Management's TECH Position: Q3 2018 in Review

TimesSquare Capital Management sold out of Bio-Techne (TECH) in Q3 2018, closing a stake of 1,100,000 shares — an estimated $40.7M sold.

TimesSquare Capital Management first reported a position in TECH in Q4 2017 and held it in 3 quarters. The position peaked at $77.5M in Q1 2018. 344 funds tracked by Wall St. Rank hold TECH as of Q3 2018.

  • TimesSquare Capital Management reported no remaining Bio-Techne position as of Q3 2018 after selling out during the quarter.
  • TimesSquare Capital Management sold 1,100,000 Bio-Techne shares in Q3 2018, an estimated $40.7M.
  • TimesSquare Capital Management first reported a position in Bio-Techne in Q4 2017 and held it in 3 quarters.
  • TimesSquare Capital Management's Bio-Techne position peaked at $77.5M in Q1 2018.
  • 344 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2018.

Based on TimesSquare Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.